Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Superior limbic keratoconjunctivitis

Other Names for this Disease
  • SLK
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might superior limbic keratoconjunctivitis (SLK) be treated?

The most common treatment is large diameter contact lens wear. Other options include cryotherapy and surgery, including conjunctival resection of the superior limbal conjunctiva and thermal cautery of superior limbal conjunctiva, which may be curative.[1][2]

More detailed information related to the treatment of SLK can be accessed through Medscape Reference.

Last updated: 7/24/2012

  1. Papaliodis GN. Superior Limbic Keratoconjunctivitis. The Ocular Immunology and Uveitis Foundation. Accessed 7/23/2012.
  2. Fraunfelder FW. Liquid nitrogen cryotherapy of superior limbic keratoconjunctivitis. Am J Ophthalmol. 2009; Accessed 7/23/2012.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Superior limbic keratoconjunctivitis. Click on the link to go to to read descriptions of these studies.
  • The U.S. National Institutes of Health, through the National Library of Medicine, developed to provide patients, family members, and members of the public with current information on clinical research studies. There is a study titled Screening Study for the Evaluation and Diagnosis of Potential Research Participants which may be of interest to you. To find this trial, click on the link above.